MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the Company will release its fourth quarter and year-end 2023 financial results before the market opens on Thursday, March 21, 2024. MiNK executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and to provide a corporate update.

Conference Call

Dial-in numbers: 646-307-1963 (U.S. – NY), 800-715-9871 (U.S. & Canada)

Conference ID: 1391457

Webcast

A live webcast and replay of the conference call will be accessible from the Events & Presentations page of the Company’s website at https://investor.minktherapeutics.com/events-and-presentations and via https://edge.media-server.com/mmc/p/xa2m5uy7.

About MiNK Therapeutics

MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. The company is headquartered in New York, NY. For more information, visit https://minktherapeutics.com/ or @MiNK_iNKT. Information that may be important to investors will be routinely posted on our website and social media channels.

Investor Contact

917-362-1370

investor@minktherapeutics.com

Media Contact

781-674-4428

communications@minktherapeutics.com

Staff

Recent Posts

New Jersey Innovation Institute and Cognome Announce Strategic Partnership to Advance AI-Powered Healthcare Solutions

NEWARK, N.J., March 26, 2025 /PRNewswire/ -- The New Jersey Innovation Institute (NJII), and Cognome are…

2 hours ago

Buds Technology Unveils BudLogic V2: BudLogic V2 Empowers Hospice Providers with Data-Driven Productivity & Performance Insights

ROSWELL, Ga., March 26, 2025 /PRNewswire/ -- Buds Technology, a leader in innovative care management…

2 hours ago

DATAVANTAGE & ADVIZEX PARTNER TO ADVANCE AI-DRIVEN DATA PREP AND XaaS DATA SECURITY, GOVERNANCE

The relationship sets a new standard for AI-driven data preparation: Deliver seamless, end-to-end secure data…

2 hours ago

HOTELTONIGHT LAUNCHES EXCLUSIVE PERK: EARN AIRBNB CREDIT WITH EVERY HOTEL STAY

Bridging the gap between hotel and homestays, HotelTonight and Airbnb provide a flexible solution for…

2 hours ago

Comcast Business Expands Connectivity Solutions to Central Florida and Tampa Bay

Florida's Technology Leader Launches New Client Services Teams in Orlando and Tampa ORLANDO, Fla., March…

2 hours ago

Uncompromised Excellence: City of Peachtree City, GA Modernizes Emergency Response with Avive’s Connected AEDs–Life Already Saved

SAN FRANCISCO  , March 26, 2025 /PRNewswire/ -- In a bold move to strengthen emergency…

2 hours ago